MUTATIONS OF THE BCR-ABL- KINASE DOMAIN EXPLAIN THE IMATINIB FAILURE ONLY IN A MINORITY OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA

被引：0
|
作者：
Jardan, D. [1 ]
Talmaci, R. [1 ]
Coriu, D. [2 ]
Dragomir, M. [2 ]
Ursuleac, I. [1 ]
机构：
[1] Univ Med & Pharm Carol Davila, Bucharest, Romania
[2] Fundeni Clin Inst, Bucharest, Romania
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1333
引用
收藏
页码：540 / 540
页数：1
相关论文
共 50 条
  • [1] Detection of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on imatinib
    Chahardouli, Bahram
    Zaker, Farhad
    Mousavi, Seied Asadollah
    Saffari, Zeinab
    Nadali, Fatemeh
    Ostadali, Mohammadreza
    Ghadimi, Habibeh
    Alimoghaddam, Kamran
    Ghavamzade, Ardeshir
    Rostami, Shahrbano
    HEMATOLOGY, 2013, 18 (06) : 327 - 332
  • [2] BCR- ABL KINASE MUTATIONS TO IMATINIB RESISTANCE IN CHRONIC MYELOID LEUKEMIA
    Thungappa, S. Chiradoni
    Singh, T.
    Rashmi, N. R.
    Lokanatha, D.
    Rajshekar, H.
    Lakshmaiah, K. C.
    Babu, K. G.
    Suresh, T. M.
    ANNALS OF ONCOLOGY, 2010, 21 : 357 - 357
  • [3] Characteristics of BCR–ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients
    YaZhen Qin
    ShanShan Chen
    Bin Jiang
    Qian Jiang
    Hao Jiang
    JinLan Li
    LingDi Li
    YueYun Lai
    YanRong Liu
    XiaoJun Huang
    Annals of Hematology, 2011, 90 : 47 - 52
  • [4] Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients
    Chandrasekhar, Chodimella
    Kumar, Pasupuleti Santhosh
    Sarma, Potukuchi Venkata Gurunadha Krishna
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [5] Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients
    Chodimella Chandrasekhar
    Pasupuleti Santhosh Kumar
    Potukuchi Venkata Gurunadha Krishna Sarma
    Scientific Reports, 9
  • [6] Primary imatinib resistance in chronic myeloid leukemia patients in a developing country: BCR-ABL kinase domain mutations or BCR-ABL independent mechanisms?
    Yap, E.
    Tumian, N. R.
    Azma, R. Z.
    Sharifah, N. A.
    Salwati, S.
    Hamidah, N. H.
    Elias, M. H.
    Wong, C. L.
    MALAYSIAN JOURNAL OF PATHOLOGY, 2017, 39 (02) : 107 - 113
  • [7] Characteristics of BCR-ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients
    Qin, YaZhen
    Chen, ShanShan
    Jiang, Bin
    Jiang, Qian
    Jiang, Hao
    Li, JinLan
    Li, LingDi
    Lai, YueYun
    Liu, YanRong
    Huang, XiaoJun
    ANNALS OF HEMATOLOGY, 2011, 90 (01) : 47 - 52
  • [8] Incidence of Bcr-Abl kinase domain mutations in imatinib refractory chronic myeloid leukemia patients from South India
    Kagita, Sailaja
    Uppalapati, Srihari
    Jiwatani, Sangeeta
    Linga, Vijay Gandhi
    Gundeti, Sadasivudu
    Nagesh, Narayana
    Digumarti, Raghunadharao
    TUMOR BIOLOGY, 2014, 35 (07) : 7187 - 7193
  • [9] ABL KINASE DOMAIN MUTATIONS IN IMATINIB-TREATED EGYPTIAN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Elnahass, Y.
    Mahmoud, H. K.
    HAEMATOLOGICA, 2014, 99 : 596 - 597
  • [10] BCR-ABL kinase domain mutations in chronic myeloid leukemia - Not quite enough to cause resistance to imatinib therapy?
    Lange, T
    Park, B
    Willis, SG
    Deininger, MWN
    CELL CYCLE, 2005, 4 (12) : 1761 - 1766
12345